Fanslow, III; William C.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Fanslow, III; William C..The latest application filed is for "combinations of anti-pd1 and anti-ctla4 antibodies".
- Fanslow, III; William C. - Normandy Park WA
- Fanslow, III; William C - Normandy Park WA US
- Fanslow, III; William C. - Seattle WA
- Fanslow, III; William C. - Federal Way WA
| Patent | Date |
|---|---|
| Fc-containing molecules exhibiting predictable, consistent, and reproducible glycoform profiles Grant 11,427,627 - Du , et al. August 30, 2 | 2022-08-30 |
| Combinations Of Anti-pd1 And Anti-ctla4 Antibodies App 20220267446 - LIU; Zhi ; et al. | 2022-08-25 |
| BCMA antigen binding proteins Grant 10,465,009 - Armitage , et al. No | 2019-11-05 |
| BCMA Antigen binding proteins Grant 10,220,090 - Armitage , et al. | 2019-03-05 |
| Bcma Antigen Binding Proteins App 20190008974 - ARMITAGE; Richard J. ; et al. | 2019-01-10 |
| Bcma Antigen Binding Proteins App 20170165373 - ARMITAGE; Richard J. ; et al. | 2017-06-15 |
| CD27L antigen binding proteins Grant 9,574,008 - Delaney , et al. February 21, 2 | 2017-02-21 |
| Fc-containing Molecules Exhibiting Predictable, Consistent, And Reproducible Glycoform Profiles App 20160207980 - DU; Zhimei ; et al. | 2016-07-21 |
| BCMA antigen binding proteins Grant 9,243,058 - Armitage , et al. January 26, 2 | 2016-01-26 |
| Bcma Antigen Binding Proteins App 20150344583 - ARMITAGE; Richard J. ; et al. | 2015-12-03 |
| Cd27l Antigen Binding Proteins App 20150218284 - DELANEY; John M. ; et al. | 2015-08-06 |
| Bcma Antigen Binding Proteins App 20140161828 - ARMITAGE; Richard J. ; et al. | 2014-06-12 |
| Tweak receptor Grant 8,414,895 - Kim , et al. April 9, 2 | 2013-04-09 |
| ULBP2 polypeptides Grant 8,410,252 - Cosman , et al. April 2, 2 | 2013-04-02 |
| Ulbp Antibodies App 20110281789 - Cosman; David J. ; et al. | 2011-11-17 |
| Tweak Receptor App 20110020267 - Kim; Kristine M. ; et al. | 2011-01-27 |
| Endothelial stem cells, populations, methods of isolation and use thereof Grant 7,833,697 - Fanslow, III , et al. November 16, 2 | 2010-11-16 |
| TWEAK receptor Grant 7,829,675 - Kim , et al. November 9, 2 | 2010-11-09 |
| ULBP antibodies Grant 7,807,796 - Cosman , et al. October 5, 2 | 2010-10-05 |
| ULBP antibodies App 20090324597 - Cosman; David J. ; et al. | 2009-12-31 |
| Antibodies to angiogenesis inhibiting domains of CD148 App 20090263383 - Smothers; James F. ; et al. | 2009-10-22 |
| Tweak Receptor App 20090137036 - KIM; KRISTINE M. ; et al. | 2009-05-28 |
| TWEAK receptor Grant 7,495,086 - Kim , et al. February 24, 2 | 2009-02-24 |
| Antibodies of angiogenesis inhibiting domains CD148 Grant 7,449,555 - Fanslow, III , et al. November 11, 2 | 2008-11-11 |
| ULBP antibodies Grant 7,427,669 - Cosman , et al. September 23, 2 | 2008-09-23 |
| CD40-Ligand lacking native-pattern glycosylation Grant 7,405,270 - Armitage , et al. July 29, 2 | 2008-07-29 |
| ULBP antibodies Grant 7,193,058 - Cosman , et al. March 20, 2 | 2007-03-20 |
| Nectin polypeptides Grant 7,175,849 - Baum , et al. February 13, 2 | 2007-02-13 |
| Use of integrin antagonists to inhibit angiogenesis Grant 7,074,408 - Fanslow, III , et al. July 11, 2 | 2006-07-11 |
| Tek antagonists Grant 7,067,475 - Cerretti , et al. June 27, 2 | 2006-06-27 |
| ULBP DNA and polypeptides Grant 6,774,224 - Cosman , et al. August 10, 2 | 2004-08-10 |
| Ligand for CD7 and methods for use thereof Grant 6,762,030 - Lyman , et al. July 13, 2 | 2004-07-13 |
| ULBP DNA and polypeptides Grant 6,653,447 - Cosman , et al. November 25, 2 | 2003-11-25 |
| Defective CD4+T-cells that express active CD40-L Grant 6,613,320 - Spriggs , et al. September 2, 2 | 2003-09-02 |
| ULBP DNA and polypeptides Grant 6,458,350 - Cosman , et al. October 1, 2 | 2002-10-01 |
| Vaccine delivery system Grant 5,900,238 - Gombotz , et al. May 4, 1 | 1999-05-04 |
| Antibodies to CD40 Grant 5,801,227 - Fanslow, III , et al. September 1, 1 | 1998-09-01 |
| Cytokine which is a ligand for OX40 Grant 5,783,665 - Baum , et al. July 21, 1 | 1998-07-21 |
| Detection of mutations in a CD40 ligand gene Grant 5,565,321 - Spriggs , et al. October 15, 1 | 1996-10-15 |
| Cytokine which is a ligand for OX40 Grant 5,457,035 - Baum , et al. Oc | 1995-10-10 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 